Company Filing History:
2 out of 832,880 Years Active: 2013-2016
Title: Innovations of Fernando Guillermo Abarzua Cabezas
Introduction
Fernando Guillermo Abarzua Cabezas is a notable inventor based in Okayama, Japan. He has made significant contributions to the field of cancer therapeutics, particularly through his innovative work involving the REIC/Dkk-3 gene. With a total of 2 patents, his inventions focus on inducing apoptosis in cancer cells, which is crucial for developing effective cancer treatments.
Latest Patents
Abarzua Cabezas' latest patents include the "Direct administration of REIC/Dkk-3 to mesothelioma." This invention provides an inducer of apoptosis in cancer cells comprising a fragment of the REIC/Dkk-3 gene and a cancer therapeutic agent. It also includes a polynucleotide fragment encoding the REIC/Dkk-3 protein, which can either be a polypeptide with a specific amino acid sequence or a modified version of that sequence. Another significant patent is the "Partial fragment of REIC/Dkk-3 gene and cancer therapeutic agent comprising the same." This invention similarly focuses on inducing apoptosis in cancer cells through the REIC/Dkk-3 gene.
Career Highlights
Throughout his career, Abarzua Cabezas has worked with various companies, including Kumon. His experience in the field has allowed him to develop innovative solutions that address critical health challenges.
Collaborations
Some of his notable coworkers include Hiromi Kumon and Nam-Ho Huh. Their collaboration has likely contributed to the advancements in his research and inventions.
Conclusion
Fernando Guillermo Abarzua Cabezas is a prominent inventor whose work in cancer therapeutics has the potential to make a significant impact on treatment options for patients. His innovative patents reflect his dedication to advancing medical science and improving patient outcomes.